A moderate or lower level of PD-1 expression in CD44+CD8+ TIL cells (Supplementary Figure S2E) facilitated the long-term maintenance of CD8+ TIL cells, thus providing sustained tumor control. The gene discussed is PDCD1; the disease is neoplasm.